Wuzhou Zhongheng Raises Money for M&A Fund
April 15, 2014 at 04:01 AM EDT
Guangxi Wuzhou Zhongheng Group will establish a pharma M&A fund with partners that could be as large as $162 million. The partners are Wuzhou Zhongheng’s largest shareholder, Guangxi Zhongheng Industrial, plus Beijing Sensegain Investment and other limited partners. Each partner will contribute a specified proportion once a suitable pharmaceutical investment is identified. The specific proportion is 29% by Zhongheng, 20% by Zhongheng Industrial, and 51% by Sensegain and other investors. More details.... Stock Symbol: (SHA: 600252) Share this with colleagues: // //